209 Items, 11 Pages <<Prev 2 3 4 5 6 7 8 9 10 11 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 121 | Lysine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 122 | margarate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 123 | Mean arterial pressure | Blood pressure | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 124 | Metabolic syndrome | Metabolic syndrome(MetS) | Diseases | Clinical characteristics | No statistical significance factor | 2 |
| 125 | Metabolic syndromeb | Metabolic syndrome(MetS) | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 126 | Metformin | Antidiabetic | Drug | Clinical characteristics | Protective factor No statistical significance factor | 2 |
| 127 | Methionine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 3 |
| 128 | myristate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 129 | myristoleate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 130 | No Diabetes | Diabetes | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 131 | No. gonorrhea episodes | STD | Diseases | Clinical characteristics | Risk factor | 1 |
| 132 | No. of different types of STIs | STD | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 133 | No. of HSV-2/HHV-8 seropositive responses | STD | Diseases | Clinical characteristics | Reference | 1 |
| 134 | No. of seropositive responses | STD | Diseases | Clinical characteristics | Reference | 1 |
| 135 | Non BPH-history | Prostate diseases | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 136 | Nonaspirin NSAID | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 137 | Nucleotide excision repair | Nucleotide excision repair(NERC) | Surgery | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 138 | Nucleotide excision repair Median cut-off | Nucleotide excision repair(NERC) | Surgery | Clinical characteristics | Risk factor | 1 |
| 139 | Nucleotides:2\'-Deoxyuridine | Nucleotides | Biochemical examination | Clinical characteristics | Reference | 0 |
| 140 | Nucleotides:Adenosine 5\'-monophosphate,AMP | Nucleotides | Biochemical examination | Clinical characteristics | Reference | 0 |